Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.5K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.

Advances in therapy·2026
Same author

Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Haematology·2026
Same author

Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Haematology·2026
Same author

Capacity Over Cognition: A Case of High-Risk Disease and Homelessness.

HCA healthcare journal of medicine·2025
Same author

Characterizing Elephant MDM2's Role in p53 Regulation.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

Phylogenomic Identification of a Highly Conserved Copper-Binding RiPP Biosynthetic Gene Cluster in Marine <i>Microbulbifer</i> Bacteria.

ACS chemical biology·2025

Related Experiment Video

Updated: Aug 9, 2025

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
10:00

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling

Published on: October 28, 2014

28.3K

Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression.

William H Yang1, Andrew P George1, Chiung-Min Wang1

  • 1Department of Biomedical Sciences, Mercer University School of Medicine, Savannah, GA 31404, USA.

Current Oncology (Toronto, Ont.)
|February 24, 2023
PubMed
Summary

The tumor suppressor p53 directly regulates programmed cell death protein 4 (PDCD4) expression. This newly discovered p53-PDCD4 interaction may play a role in tumor development and progression.

Keywords:
PDCD4p53transcriptional activity

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.6K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.0K

Related Experiment Videos

Last Updated: Aug 9, 2025

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
10:00

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling

Published on: October 28, 2014

28.3K
Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.6K
Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
08:37

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

10.0K

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cellular Regulation

Background:

  • Programmed cell death protein 4 (PDCD4) is a tumor suppressor that inhibits translation initiation.
  • PDCD4 binds to EIF4A, preventing the translation of specific mRNAs, and can inhibit neoplastic transformation.
  • Previous studies showed PDCD4 inhibits p53 mRNA translation and that DNA-damaging agents alter the expression of both p53 and PDCD4.

Purpose of the Study:

  • To investigate whether p53 directly regulates the expression of PDCD4.
  • To elucidate the mechanism by which p53 might regulate PDCD4.
  • To determine the role of specific p53 domains and mutations in PDCD4 regulation.

Main Methods:

  • Overexpression of p53 in p53-null cancer cell lines (H1299, Saos2).
  • Gene reporter assays to assess PDCD4 promoter activity.
  • Site-directed mutagenesis of p53 and analysis of PDCD4 repression.
  • Truncation studies of the p53 C-terminal regulatory domain.

Main Results:

  • Overexpression of p53 led to decreased PDCD4 protein levels in p53-null cells.
  • p53 significantly decreased PDCD4 promoter activity.
  • Specific p53 mutations (R273H, R175H) and mutations in the DNA-binding domain abolished p53-mediated PDCD4 repression.
  • The region between amino acids 374 and 370 in p53's C-terminal regulatory domain was critical for PDCD4 repression.

Conclusions:

  • p53 directly regulates PDCD4 expression, acting as a novel regulator.
  • The DNA-binding domain and a specific region in the C-terminal regulatory domain of p53 are essential for PDCD4 repression.
  • The newly identified p53-PDCD4 regulatory axis is potentially involved in tumor development and progression.